000 01302 a2200409 4500
005 20250514042144.0
264 0 _c20030116
008 200301s 0 0 eng d
022 _a1528-9117
024 7 _a10.1097/00130404-200207000-00010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKrieger, Jim A
245 0 0 _aImplementation and results of a test dose program with taxanes.
_h[electronic resource]
260 _bCancer journal (Sudbury, Mass.)
_c
300 _a337-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBridged-Ring Compounds
_xadverse effects
650 0 4 _aCost Savings
650 0 4 _aDrug Costs
650 0 4 _aDrug Hypersensitivity
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPilot Projects
650 0 4 _aTaxoids
700 1 _aStanford, Brad L
700 1 _aBallard, Erin E
700 1 _aRabinowitz, Ian
773 0 _tCancer journal (Sudbury, Mass.)
_gvol. 8
_gno. 4
_gp. 337-41
856 4 0 _uhttps://doi.org/10.1097/00130404-200207000-00010
_zAvailable from publisher's website
999 _c12066810
_d12066810